sunresin(SZ:300487) Great Wall Securities·2025-09-10 07:37Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase of over 15% relative to the industry index in the next six months [5][11][19]. Core Viewpoints - The company has achieved breakthroughs in its lithium extraction project in Tibet and is planning to build a high-end materials industrial park for life sciences, which is expected to enhance its growth potential [4][10][11]. - The company's revenue for the first half of 2025 was 1.247 billion yuan, a year-on-year decrease of 3.64%, while the net profit attributable to shareholders increased by 10.01% to 445 million yuan [1][2]. - The growth in the company's performance is primarily driven by its businesses in life sciences, metal resources, water treatment, and ultra-purification, alongside a decrease in raw material costs [2][4]. Financial Summary - The company projects revenues of 3.067 billion yuan, 3.748 billion yuan, and 4.477 billion yuan for 2025, 2026, and 2027 respectively, with corresponding net profits of 970 million yuan, 1.222 billion yuan, and 1.516 billion yuan [11][12]. - The company's return on equity (ROE) is expected to remain strong, with figures of 21.1%, 22.1%, and 22.5% for 2025, 2026, and 2027 respectively [11][12]. - The earnings per share (EPS) are projected to be 1.91 yuan, 2.41 yuan, and 2.99 yuan for the years 2025, 2026, and 2027 [11][12]. Business Performance - The company reported a gross margin of 51.26% in the first half of 2025, an increase of 3.78 percentage points year-on-year, indicating improved profitability [2][4]. - The life sciences segment generated revenue of 320 million yuan in the first half of 2025, reflecting a year-on-year growth of 12.43% [10]. - The company has completed and is executing 12 lithium extraction projects, with a combined capacity of nearly 100,000 tons of lithium carbonate/hydroxide [4][9].